2025 annual financial data
Mirum Pharmaceuticals 2025 Operating margin
Mirum Pharmaceuticals 2025 operating margin with verified reported values.
Direct answer
Operating margin was -4.25%.
Operating income was -22,136,000 USD and net income was -23,363,000 USD.
Operating cash flow was 55,827,000 USD.
Get free Mirum Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 521,312,000 USD
- Operating income
- -22,136,000 USD
- Net income
- -23,363,000 USD
- Operating cash flow
- 55,827,000 USD